BPMUF | Basilea Pharmaceutica AG Annual & Quarterly

Annual Balance Sheets

(In CHF)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	173.28 Million	220.84 Million	247.26 Million	229.79 Million	221.46 Million	281.75 Million
Total Current Assets	152.14 Million	175.36 Million	241.06 Million	223.52 Million	184.86 Million	274.73 Million
Cash And Short Term Investments	59.9 Million	84.7 Million	148.7 Million	161.72 Million	129 Million	223.9 Million
Cash and Cash Equivalents	59.9 Million	84.7 Million	53.7 Million	60.7 Million	109 Million	38.3 Million
Short Term Investments	51.83 Million	50 Million	95 Million	101.02 Million	20 Million	185.6 Million
Net Receivables	62.58 Million	63.66 Million	65.7 Million	37.91 Million	30.36 Million	34.71 Million
Inventory	26.41 Million	24.24 Million	22.78 Million	21.19 Million	18.56 Million	14.41 Million
Other Current Assets	3.25 Million	2.76 Million	3.88 Million	2.69 Million	6.92 Million	1.7 Million
Total Non-Current Assets	21.14 Million	45.48 Million	6.2 Million	6.26 Million	36.6 Million	7.01 Million
Net PPE	20.6 Million	21.6 Million	2.9 Million	5.24 Million	5.16 Million	6.42 Million
Good Will And Intangible Assets	548 Thousand	578 Thousand	632 Thousand	672 Thousand	372 Thousand	372 Thousand
Good Will	-	-	-	-	-	-
Intangible Assets	548 Thousand	578 Thousand	632 Thousand	672 Thousand	372 Thousand	372 Thousand
Long-Term Investments	-	23.26 Million	-92.61 Million	-	10 Million	-
Tax Assets	-	-23.26 Million	95 Million	-	20 Million	-
Other Non Current Assets	-4000.00	23.3 Million	279 Thousand	346 Thousand	1.07 Million	216.99 Thousand
Other Assets	-	-	-	-	-	1.00
Total Liabilities	183.29 Million	265.85 Million	305.87 Million	331.84 Million	314.42 Million	348.43 Million
Total Current Liabilities	47.59 Million	74.85 Million	174.4 Million	50.16 Million	75.49 Million	66.68 Million
Account Payables	5.84 Million	191 Thousand	10.61 Million	13.15 Million	6.76 Million	6.39 Million
Tax Payables	-	1 Million	1.5 Million	1.6 Million	1.1 Million	8.6 Million
Short Term Debt	17.51 Million	39.45 Million	124.4 Million	1.75 Million	-32.87 Million	8.6 Million
Deferred Revenue	16.83 Million	27.13 Million	33.83 Million	29.85 Million	32.87 Million	25.02 Million
Other Current Liabilities	7.39 Million	8.07 Million	5.55 Million	5.4 Million	68.72 Million	26.66 Million
Total Non Current Liabilities	135.69 Million	191 Million	131.46 Million	281.67 Million	238.93 Million	281.75 Million
Long-Term Debt	111.09 Million	147.68 Million	94.55 Million	240.56 Million	197.74 Million	196.98 Million
Deferred Revenue Non Current	9.46 Million	10.69 Million	11.92 Million	13.15 Million	16.47 Million	69.94 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	15.14 Million	32.63 Million	24.98 Million	27.95 Million	24.72 Million	14.82 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	-10 Million	-45 Million	-58.6 Million	-102.04 Million	-92.96 Million	-66.68 Million
Stock Holders Equity	-10 Million	-45 Million	-58.6 Million	-102.04 Million	-92.96 Million	-66.68 Million
Common Stock	13.1 Million	13.09 Million	12.99 Million	11.92 Million	11.88 Million	11.87 Million
Retained Earnings	-1 Billion	-1.03 Billion	-1.02 Billion	-1.01 Billion	-1 Billion	-979.22 Million
Accumulated other comprehensive income	-10.21 Million	-3.78 Million	-21.61 Million	-27.25 Million	-24.55 Million	-16.3 Million
Common Stock Equity	-10 Million	-45 Million	-58.6 Million	-102.04 Million	-92.96 Million	-66.68 Million
Capital Lease Obligation	17.69 Million	18.31 Million	906 Thousand	2.64 Million	900 Thousand	-
Total Investments	51.83 Million	73.26 Million	2.39 Million	101.02 Million	30 Million	185.6 Million
Total Debt	128.6 Million	187.13 Million	218.95 Million	242.31 Million	197.74 Million	196.98 Million
Net Debt	68.7 Million	102.43 Million	165.25 Million	181.61 Million	88.74 Million	158.67 Million

Breakdown	2024 Q2	2023 Q4	2023 FY	2023 Q3	2023 Q2	2023 Q1
Total Assets	188.66 Million	173.28 Million	173.28 Million	173.28 Million	230.03 Million	230.03 Million
Total Current Assets	155.01 Million	152.14 Million	152.14 Million	152.14 Million	185.82 Million	185.82 Million
Cash And Short Term Investments	69.47 Million	59.9 Million	59.9 Million	59.93 Million	87.71 Million	87.71 Million
Cash and Cash Equivalents	69.47 Million	59.9 Million	59.9 Million	59.93 Million	87.71 Million	87.71 Million
Short Term Investments	-	51.83 Million	51.83 Million	-	-	-
Net Receivables	48.94 Million	62.58 Million	62.58 Million	27.89 Million	67.6 Million	39.66 Million
Inventory	31.37 Million	26.41 Million	26.41 Million	26.41 Million	25.63 Million	25.63 Million
Other Current Assets	5.21 Million	3.25 Million	3.25 Million	37.91 Million	4.87 Million	32.8 Million
Total Non-Current Assets	33.65 Million	21.14 Million	21.14 Million	21.14 Million	44.2 Million	44.2 Million
Net PPE	19.41 Million	20.6 Million	20.6 Million	20.55 Million	21.7 Million	21.65 Million
Good Will And Intangible Assets	-	548 Thousand	548 Thousand	548 Thousand	534 Thousand	534 Thousand
Good Will	-	-	-	-	-	-
Intangible Assets	-	548 Thousand	548 Thousand	548 Thousand	534 Thousand	534 Thousand
Long-Term Investments	-	-	-	-	22 Million	-
Tax Assets	13.42 Million	-	-	-	-22 Million	-
Other Non Current Assets	817 Thousand	-4000.00	-4000.00	44 Thousand	21.97 Million	22.02 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	171.87 Million	183.29 Million	183.29 Million	183.29 Million	215.04 Million	215.04 Million
Total Current Liabilities	37.78 Million	47.59 Million	47.59 Million	47.59 Million	67.18 Million	67.18 Million
Account Payables	11.47 Million	5.84 Million	5.84 Million	5.84 Million	3.94 Million	3.94 Million
Tax Payables	-	-	-	-	500 Thousand	-
Short Term Debt	2.06 Million	17.51 Million	17.51 Million	15.45 Million	39.97 Million	37.91 Million
Deferred Revenue	1.23 Million	16.83 Million	16.83 Million	-	17.13 Million	-
Other Current Liabilities	23.01 Million	7.39 Million	7.39 Million	26.29 Million	6.13 Million	25.32 Million
Total Non Current Liabilities	134.09 Million	135.69 Million	135.69 Million	135.7 Million	147.86 Million	147.86 Million
Long-Term Debt	95.68 Million	111.09 Million	111.09 Million	111.09 Million	129.79 Million	129.79 Million
Deferred Revenue Non Current	8.84 Million	9.46 Million	9.46 Million	-	10.07 Million	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	14.86 Million	15.14 Million	15.14 Million	24.6 Million	7.98 Million	18.06 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	16.78 Million	-10 Million	-10 Million	-10 Million	14.98 Million	14.98 Million
Stock Holders Equity	16.78 Million	-10 Million	-10 Million	-10 Million	14.98 Million	14.98 Million
Common Stock	13.17 Million	13.1 Million	13.1 Million	13.1 Million	13.1 Million	13.1 Million
Retained Earnings	-980.15 Million	-1 Billion	-1 Billion	-1 Billion	-979.49 Million	-979.49 Million
Accumulated other comprehensive income	-9 Million	-10.21 Million	-10.21 Million	-10.21 Million	-3.29 Million	-3.29 Million
Common Stock Equity	16.78 Million	-10 Million	-10 Million	-10 Million	14.98 Million	14.98 Million
Capital Lease Obligation	14.7 Million	17.69 Million	17.69 Million	17.69 Million	18.68 Million	18.68 Million
Total Investments	-	51.83 Million	51.83 Million	-	22 Million	-
Total Debt	112.44 Million	128.6 Million	128.6 Million	126.54 Million	169.77 Million	167.71 Million
Net Debt	42.97 Million	68.7 Million	68.7 Million	66.61 Million	82.06 Million	80 Million

Balance Sheet Charts

Wallenius Wilhelmsen ASA

0N0B

Full Analysis

Annual Balance Sheets
Neolife SA

ALNLF

Full Analysis

Annual Balance Sheets
Yuanda China Holdings Limited

2789

Full Analysis

Annual Balance Sheets
Pinestone Capital Limited

0804

Full Analysis

Annual Balance Sheets
AvalonBay Communities, Inc.

AVB

Full Analysis

Annual Balance Sheets
Genky DrugStores Co., Ltd.

9267

Full Analysis

Annual Balance Sheets

Global Stocks Search

Basilea Pharmaceutica AG (BPMUF)

Annual Balance Sheets

Balance Sheet Charts

Wallenius Wilhelmsen ASA

Neolife SA

Yuanda China Holdings Limited

Pinestone Capital Limited

AvalonBay Communities, Inc.

Genky DrugStores Co., Ltd.